Combination Therapy in Cancers With Mutations in DNA Repair Genes

NCT05694715 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Solid Tumor
BRCA1 Mutation
BRCA2 Mutation
ATM Gene Mutation
PALB2 Gene Mutation

Interventions

DRUG: Niraparib
DRUG: Irinotecan

Sponsor

University of California, San Francisco

Collaborators

[object Object]